New Multi-Virus vaccine tested in healthy adults
NCT ID NCT06850051
Summary
This early-stage study tested the safety and immune response of new combination vaccines targeting multiple respiratory viruses. Healthy adults aged 18-49 received one injection of either a flu vaccine or a combined vaccine for RSV, hMPV, and parainfluenza. Researchers monitored participants for side effects and measured antibody levels to see if the vaccines triggered protective immune responses.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Emeritus Research
Camberwell, Victoria, 3124, Australia
-
Griffith University
Southport, Queensland, 4215, Australia
-
Paratus Clinical
Blacktown, New South Wales, 2148, Australia
-
Paratus Clinical
Herston, Queensland, 4006, Australia
-
University of Sunshine Coast Clinical Trials
Morayfield, Queensland, 4506, Australia
-
University of Sunshine Coast Clinical Trials
South Brisbane, Queensland, 4101, Australia
Conditions
Explore the condition pages connected to this study.